Comparison of efficacy between trimetazidine and cilostazol in the treatment of arteriosclerosis obliterans in lower extremity

This study compared the efficacy and long-term survival rate of trimetazidine and cilostazol in the treatment of lower extremity arteriosclerosis obliterans (ASO). A retrospectively analysis on the medical records of 206 patients with ASO who were admitted to The Central Hospital of Wuhan from Janua...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Min, Wang, Dile, He, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488977/
https://www.ncbi.nlm.nih.gov/pubmed/31086577
http://dx.doi.org/10.3892/etm.2019.7472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488977/
https://www.ncbi.nlm.nih.gov/pubmed/31086577
http://dx.doi.org/10.3892/etm.2019.7472

Ejemplares similares